Frazier Life Sciences X is a Venture Capital Fund in Washington with $642.06 mm assets under management, with a minimum investment of $3.00 mm. It has 73 beneficial owners. Data from SEC filing.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
AUM ?
$642.06 mm
Address
Frazier Life Sciences X
601 UNION STREET, SUITE 3200
TWO UNION SQUARE
SEATTLE
WA 98101
601 UNION STREET, SUITE 3200
TWO UNION SQUARE
SEATTLE
WA 98101
Phone
(206) 621-7200
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Frazier Life Sciences Management, LP | $4.04 bn | |
Frazier Healthcare Vii-a, L.P. | $63.47 mm | Private Equity Fund |
Frazier Healthcare VII, L.P. | $218.28 mm | Private Equity Fund |
Frazier Life Sciences IX, L.P. | $756.28 mm | Venture Capital Fund |
Frazier Life Sciences Public Fund, L.P. | $996.41 mm | Private Equity Fund |
Frazier Life Sciences VIII, L.P. | $372.19 mm | Venture Capital Fund |
Frazier Life Sciences X, L.P. | $642.06 mm | Venture Capital Fund |
Frazier Life Sciences XI, L.P. | $987.24 mm | Venture Capital Fund |
Latest filings (excl ownership)
Latest ownership filings
4
James N Topper
8 Apr 24
SC 13D/A
NewAmsterdam Pharma Co N.V.
21 Feb 24
SC 13D/A
NewAmsterdam Pharma Co N.V.
15 Aug 23
SC 13D/A
NewAmsterdam Pharma Co N.V.
9 Jun 23
4
James N Topper
3 May 22
3
James N Topper
28 Apr 22
3/A
Patrick J Heron
17 Dec 20
4
James N Topper
11 Dec 20
3
James N Topper
8 Dec 20